Indication
MYC Amplification
1 clinical trial
2 products
Product
VIP152Clinical trial
An Open-label, Multicenter Phase 1/1b Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity, Pharmacokinetics, and Pharmacodynamics of VIP152 Monotherapy or Combination Therapy in Subjects With High-risk Chronic Lymphocytic Leukemia or Richter SyndromeStatus: Terminated, Estimated PCD: 2023-05-26
Product
BTKi